#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Angiosarcoma recurrent Pancreatic carcinoma Macular telangiectasia Follicle centre lymphoma follicular grade I, II – III Kawasaki's disease Hormone-dependent prostate cancer Endometrial cancer recurrent Cutaneous T-cell lymphoma stage II Ewing's sarcoma Neuropathy peripheral Transient ischaemic attack SAPHO syndrome Lennox-Gastaut syndrome Homocystinuria More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Basic Information Hyperoxaluria – Basic Information Marginal zone lymphoma refractory – Diagnostics Cystic fibrosis – Diagnostics Angiosarcoma recurrent – Life with Disease Crigler-Najjar syndrome – Trials in Disease Netherton’s syndrome – Trials in Disease Alternating hemiplegia of childhood – Trials in Disease Angiosarcoma non-metastatic – Basic Information Marfan’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LTI-03 Vinflunine L-Acetylleucine Vibozilimod GS-4321 Nimorazole Aluminium Hydroxide Nitrofurantoin Dalbavancin Teropavimab Zidovudine GVV858 RO7288817 Adrenaline Tartrate Ph. Eur. Losmapimod Tranexamic Acid Nortriptyline Aldesleukin AZD3632 Rezvilutamide More therapies…

    Learn about Your Condition

    Osteogenesis imperfecta Biliary tract disorder Hypervolaemia Ventricular tachycardia Impaired gastric emptying Pancreatic carcinoma Infectious pleural effusion Cushing's syndrome Factor VIII deficiency Colitis Hepatorenal syndrome Urticaria cholinergic Renal cell carcinoma stage IV Dupuytren's contracture Osteomyelitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy…

Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy

Ul. Marii Curie Sklodowskiej 9, Bydgoszcz, 85-094, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and safety of gadopiclenol versus gadoteric acid‑enhanced MRA in adult patients with suspected vascular disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Gadoteric Acid
    Czechia France Germany Hungary Italy Poland +1

  • Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Blinatumomab
    • Busulfan
    Austria Belgium Croatia Czechia Denmark Finland +10

  • A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

    Recruiting

    4 1
    Belgium France Hungary Poland Romania Spain

  • Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    Poland

  • Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Rituximab
    Poland

  • Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Crisantaspase
    • Inotuzumab Ozogamicin
    • Mitoxantrone Hydrochloride
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Pancreatic Enzyme Replacement Therapy for Adults with Pancreatic Exocrine Insufficiency After Pancreatic Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pancreas Powder
    Austria Germany Poland Spain

  • Study of Ruxolitinib and Chemotherapy Drug Combination for Children with Acute Lymphoblastic Leukemia and JAK/STAT Pathway Activation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Asparaginase
    • Daunorubicin
    • Dexamethasone Phosphate
    Poland

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daunorubicin
    • Mercaptopurine
    • Methotrexate Sodium
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Daunorubicin
    Austria Belgium Czechia Denmark Finland France +13
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!